MetaCap

AC Immune SA (ACIU) vs Whitehawk Therapeutics (WHWK)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Whitehawk Therapeutics (WHWK) has outperformed AC Immune SA (ACIU) over the past year, gaining 45.5% versus a loss of 35.0%. Over five years, ACIU leads with a -62.3% price change compared with -86.4% for WHWK. AC Immune SA is the larger company by market cap ($193.9 million vs $181.2 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACIU-35.00%WHWK+45.50%
+151%+53%-44%
Nov 21, 20251 yearNov 20, 2026
ACIU-64.35%WHWK-87.61%
+9%-45%-100%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACIU versus WHWK key metrics
MetricACIUWHWK
Share price$1.95$3.07
Market cap$193.88M$181.16M
1-day change-8.45%-1.60%
YTD return-37.90%+26.86%
1-year return-35.00%+45.50%
5-year return-62.28%-86.36%
Forward P/E2.84—
EPS (TTM)$-0.44$-1.10
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$7.14M
Revenue growth (YoY)—-72.50%
Net income (latest FY)—$-20.60M
Gross margin—89.36%
Operating margin—-1601.12%
Net margin—-288.26%
52-week high$3.90$5.50
52-week low$1.93$2.10
Distance from 52-week high-50.00%-44.13%
Analyst consensusstrong_buybuy
Avg. price target upside+331.28%+151.14%
Average volume198.81K348.68K
Shares outstanding99.43M59.01M
Employees9037
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • WHWK has outperformed ACIU by 80.5 percentage points over the past year.

About AC Immune SA

ACIU stock →

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company's SupraAntigen and Morphomer platforms are designed to generate biologics and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 90 employees

About Whitehawk Therapeutics

WHWK stock →

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer.

Health Care · Biotechnology: Pharmaceutical Preparations · 37 employees

ACIU vs WHWK FAQ

Which is bigger, AC Immune SA or Whitehawk Therapeutics?

AC Immune SA (ACIU) is larger, with a market capitalization of $193.88M compared with $181.16M for Whitehawk Therapeutics (WHWK).

Which stock has performed better over the past year, ACIU or WHWK?

WHWK returned +45.50% over the past 12 months, compared with -35.00% for ACIU (price return, excluding dividends). Past performance does not predict future results.

Are AC Immune SA and Whitehawk Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons